K. Vanstraelen

发表

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

P. Vermeersch, M. Hoenigl, P. Annaert, 2016, European Journal of Clinical Pharmacology.

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

A. Mangia, D. Dieterich, S. Solomon, 2021, Advances in Therapy.

Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment".

I. Spriet, S. Pauwels, J. Maertens, 2015, Therapeutic drug monitoring.

Chemotherapy-Induced Intestinal Mucosal Barrier Damage: a Cause of Falsely Elevated Serum 1,3-Beta-d-Glucan Levels?

M. Hoenigl, R. Krause, I. Spriet, 2015, Journal of Clinical Microbiology.

Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area

P. Vermeersch, P. Annaert, P. Augustijns, 2016, The Pediatric infectious disease journal.

The Eagle-like effect of echinocandins: what’s in a name?

I. Spriet, L. Willems, K. Lagrou, 2013, Expert review of anti-infective therapy.

Impact of Hypoalbuminemia on Voriconazole Pharmacokinetics in Critically Ill Adult Patients

H. de Loor, P. Annaert, I. Spriet, 2014, Antimicrobial Agents and Chemotherapy.

Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole

H. de Loor, P. Annaert, P. Augustijns, 2015, Clinical Pharmacokinetics.

High-throughput equilibrium dialysis to determine protein binding characteristics of voriconazole

P. Annaert, I. Spriet, L. Willems, 2013 .

Impact of hypoalbuminemia on voriconazole pharmacokinetics in adult critically ill

P. Annaert, I. Spriet, K. Lagrou, 2014 .

Influence of storage temperature on the dose uniformity of voriconazole powder for oral suspension

K. Desmet, I. Spriet, S. Pauwels, 2014 .

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders

I. Ntalla, H. Ramroth, M. Buti, 2022, Viruses.

Protein-binding characteristics of voriconazole determined by high-throughput equilibrium dialysis.

H. de Loor, P. Annaert, I. Spriet, 2014, Journal of pharmaceutical sciences.

Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

I. Ntalla, H. Ramroth, F. Carrat, 2020, Liver international : official journal of the International Association for the Study of the Liver.

Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations

P. Vermeersch, A. Smits, K. Allegaert, 2015, Antimicrobial Agents and Chemotherapy.

Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings

I. Ntalla, H. Ramroth, A. Mangia, 2022, Future Virology.

Preliminary experience of routine voriconazole TDM in a tertiary care centre

I. Spriet, L. Willems, K. Lagrou, 2012 .

Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients

P. Vermeersch, M. Hoenigl, P. Annaert, 2016, European Journal of Clinical Pharmacology.

Real-world evidence of sofosbuvir/velpatasvir as an effective and simple hepatitis C virus treatment and elimination tool in homeless populations

I. Ntalla, H. Ramroth, B. Conway, 2021, Future Virology.

STIMULATION OF THE IV TO ORAL SWITCH OF BIOAVAILABLE DRUGS BY PHONE CALLS IN A BELGIAN TERTIARY CARE HOSPITAL

I. Spriet, L. Willems, W. Peetermans, 2013 .

Factors Impacting Unbound Vancomycin Concentrations in Different Patient Populations

P. Vermeersch, A. Smits, K. Allegaert, 2015, Antimicrobial Agents and Chemotherapy.